| (USD) | Sep 2023 | Q/Q |
|---|---|---|
| Revenue | 171.3MM | +1% |
| Gross Profit | 95.5MM | -2% |
| Cost Of Revenue | 75.8MM | +6% |
| Operating Income | 1.2MM | -157% |
| Operating Expenses | 94.3MM | - |
| Net Income | -3.7MM | -95% |
| R&D | 6.1MM | -10% |
| G&A | 78.7MM | -15% |
| Amortization | 6.2MM | +7% |
| Interest Expense | 4.7MM | +34% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Key Insights Avanos Medical will host its Annual General Meeting on 25th of April CEO Joe Woody's total compensation...
Avanos' (AVNS) strong product line and focus on R&D raise optimism about the stock.
Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Avanos Medical ( NYSE:AVNS ) Full Year 2023 Results Key Financial Results Revenue: US$673.3m (down 18% from FY 2022...
In direct response to the Nurse Assist, LLC voluntary recall of pre-filled syringes and other sterile water products, Avanos Medical, Inc. (NYSE: AVNS) voluntarily recalled specific lots of MIC* Gastric – Jejunal Feeding Tube Kits on Jan. 16, 2024. These kits include Nurse Assist supplied syringes, pre-filled with sterile water, essential for inflating the retention balloon of the feeding tube.
Despite strength in Avanos' (AVNS) Digestive Health segment, its overall fourth-quarter results reflect soft performances.
Avanos Medical, Inc. (NYSE:AVNS) Q4 2023 Earnings Call Transcript February 20, 2024 Avanos Medical, Inc. misses on earnings expectations. Reported EPS is $0.32 EPS, expectations were $0.37. AVNS isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and welcome […]
Full-Year Sales Dip as Company Focuses on Profitable Growth and Strategic Acquisitions
Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2023 results.
Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2023 on Tuesday, Feb. 20 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day.